Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

WearLinq

Explore full profile

WearLinq is a provider of digital healthcare solutions with a focus on ambulatory electrocardiogram (ECG) monitoring

San Francisco, United StatesFounded 2020Health Tech & Medtech
Valuation $50–100M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for WearLinq and the history behind them.

About WearLinq

WearLinq is a digital healthcare solutions provider specializing in ambulatory electrocardiogram (ECG) monitoring to improve the detection of heart rhythm disorders. The company was established in 2019 by Konrad Morzkowski, who serves as the CEO. Morzkowski, an engineer from Sweden, pursued a Master of Science at Stanford where he connected with his co-founders. His initial plan was to build AI applications for healthcare, but an introduction to a group of scientists led to the creation of WearLinq.

The company's core offering is the eWave, a wearable 6-lead ECG monitor that has received FDA 510(k) clearance. This device is designed for the continuous, long-term monitoring of patients who may have transient symptoms like palpitations, dizziness, or fatigue. The eWave system provides cardiologists with a detailed, multidimensional view of the heart, ensuring P-wave visibility and ECG clarity. Designed to be lightweight and discreet, the monitor magnetically attaches to skin-like adhesive patches and is intended to be minimally intrusive, allowing patients to maintain their daily routines. The device features a rechargeable battery with up to five days of use on a single charge and comes with an AirPods-like charging case. It integrates with a patient's smartphone and a cloud platform, enabling near real-time data analysis and actionable insights for healthcare providers.

WearLinq's business model focuses on providing these advanced cardiac monitoring services to patients and clinical facilities. A key strategic move was the acquisition of AMI Cardiac Monitoring in May 2024. This acquisition of an established independent diagnostic testing facility (IDTF) with over three decades of experience expanded WearLinq's clinical service capabilities nationwide across all 50 states. Through its IDTF, Wearlinq Labs, the company offers high-quality cardiology reports delivered within two days, and STAT reports produced daily. The company has secured $12.3 million in funding over two rounds, including investments from Smartlink Partners and Amino Capital.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
San Francisco, United States
Employees
51
Open positions
1
Dealroom signal
91.2/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Health Diagnostics, Spinout, Wearable, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest May 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 $14M $56M Amino Capital · XB Ventures · Solasta Ventures · Celtic House Asia Partners ↗
SEED✓Equity / VC Oct 2024 $700K $2.8M Smartlink Partners ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

WearLinq website traffic

Latest recorded traffic for WearLinq is 93K monthly website visits, up 447.1% over the last three months. WearLinq's team grew 168.4% over the past year.

Latest monthly visits93K 3-month web change+447.1% 1-year team growth+168.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Smartlink Partners

Series A14 investors entered at this stage

  • AIX Ventures
  • Amino Capital
  • XB Ventures
  • Solasta Ventures
  • Celtic House Asia Partners
  • Angelschool
  • Device of Tomorrow Capital
  • Berkeley Catalyst Fund
  • SpringTide
  • Lightscape Partners
  • MALIAM
  • LDV Partners
  • Alumni Ventures
  • NX Venture Partner

Other known investors1 additional known investor

  • Stanford University
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States72.2%
🇵🇱 Poland19.4%
🇸🇬 Singapore5.6%
🇹🇭 Thailand2.8%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about WearLinq on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See WearLinq’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.